This announcement is a separate document:
永泰生物-B：建議根據一般授權發行可換股債券及一名主要股東訂立股份認購權契據
Immunotech Biopharm Ltd-B: PROPOSED ISSUE OF CONVERTIBLE BONDSUNDER GENERAL MANDATEANDCALL OPTION DEED BYA SUBSTANTIAL SHAREHOLDER
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.